Lv2
175 积分 2022-06-08 加入
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
8天前
已完结
Incidence of Programmed Cell Death 1 Inhibitor–Related Pneumonitis in Patients With Advanced Cancer
8天前
已完结
Treatment Sequencing in Resectable Lung Cancer: The Good and the Bad of Adjuvant Versus Neoadjuvant Therapy
8天前
已完结
Improved treatment outcome of pembrolizumab in patients with nonsmall cell lung cancer and chronic obstructive pulmonary disease
8天前
已完结
Lung cancer — major changes in the American Joint Committee on Cancer eighth edition cancer staging manual
5个月前
已完结
Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
5个月前
已完结
Spontaneous histological transformation of lung squamous-cell carcinoma to large cell neuroendocrine carcinoma and small cell lung cancer
7个月前
已完结
Histologic Transformation in EGFR-Mutant Lung Adenocarcinomas: Mechanisms and Therapeutic Implications
7个月前
已完结
Histological Transformation to Large Cell Neuroendocrine Carcinoma from Lung Adenocarcinoma Harboring an <i>EGFR</i> Mutation: An Autopsy Case Report
7个月前
已关闭
Distinguishing multiple primary lung cancers from intrapulmonary metastasis using CT-based radiomics
8个月前
已完结
皖公网安备34019202002308
